Status:
COMPLETED
Tailored Therapy for Helicobacter Pylori Rescue Treatment
Lead Sponsor:
Shanghai Jiao Tong University School of Medicine
Conditions:
Helicobacter Pylori Infection
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
With increasing antibiotic resistance and unsatisfactory results of empiric eradication regimens, tailored therapy may be the best choice to achieve high efficacy for rescue treatment. This study aime...
Eligibility Criteria
Inclusion
- Participants with non-ulcer functional dyspepsia or scarred peptic ulcer disease
- Previous failures of H. pylori eradication therapy and need rescue therapy
- Ability and willingness to participate in the study and to sign and give informed consent
- Confirmed H. pylori infection
Exclusion
- Less than 18 years old
- With previous gastric surgery
- Major systemic diseases
- Pregnancy or lactation
- Allergy to any of the study drugs
- Administration of antibiotics, bismuth, antisecretory drugs in 8 weeks prior to inclusion
Key Trial Info
Start Date :
January 3 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2018
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03413020
Start Date
January 3 2018
End Date
July 31 2018
Last Update
August 7 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
Shanghai, Shanghai Municipality, China, 200127